Logo image of SREA

SEMPRA - SRE 5 3/4 07/01/2079 (SREA) Stock Fundamental Analysis

USA - NYSE:SREA - US8168516040

22.02 USD
-0.06 (-0.27%)
Last: 11/19/2025, 2:37:34 PM
Fundamental Rating

4

SREA gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 26 industry peers in the Multi-Utilities industry. There are concerns on the financial health of SREA while its profitability can be described as average. SREA has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year SREA was profitable.
SREA had a positive operating cash flow in the past year.
Each year in the past 5 years SREA has been profitable.
SREA had a positive operating cash flow in each of the past 5 years.
SREA Yearly Net Income VS EBIT VS OCF VS FCFSREA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B -4B 6B

1.2 Ratios

SREA has a Return On Assets of 1.97%. This is amonst the worse of the industry: SREA underperforms 80.77% of its industry peers.
SREA's Return On Equity of 6.77% is on the low side compared to the rest of the industry. SREA is outperformed by 80.77% of its industry peers.
SREA's Return On Invested Capital of 2.94% is on the low side compared to the rest of the industry. SREA is outperformed by 92.31% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SREA is in line with the industry average of 3.96%.
Industry RankSector Rank
ROA 1.97%
ROE 6.77%
ROIC 2.94%
ROA(3y)3.02%
ROA(5y)3.29%
ROE(3y)9.1%
ROE(5y)9.64%
ROIC(3y)3.3%
ROIC(5y)3.52%
SREA Yearly ROA, ROE, ROICSREA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

SREA has a Profit Margin of 15.38%. This is amongst the best in the industry. SREA outperforms 84.62% of its industry peers.
SREA's Profit Margin has improved in the last couple of years.
SREA's Operating Margin of 22.51% is fine compared to the rest of the industry. SREA outperforms 69.23% of its industry peers.
SREA's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 22.51%
PM (TTM) 15.38%
GM N/A
OM growth 3Y0.45%
OM growth 5Y-2.46%
PM growth 3Y29.87%
PM growth 5Y2.38%
GM growth 3YN/A
GM growth 5YN/A
SREA Yearly Profit, Operating, Gross MarginsSREA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

3

2. Health

2.1 Basic Checks

SREA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
SREA has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SREA has been increased compared to 5 years ago.
The debt/assets ratio for SREA is higher compared to a year ago.
SREA Yearly Shares OutstandingSREA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
SREA Yearly Total Debt VS Total AssetsSREA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

Based on the Altman-Z score of 0.69, we must say that SREA is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.69, SREA is in line with its industry, outperforming 42.31% of the companies in the same industry.
A Debt/Equity ratio of 1.02 is on the high side and indicates that SREA has dependencies on debt financing.
With an excellent Debt to Equity ratio value of 1.02, SREA belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF N/A
Altman-Z 0.69
ROIC/WACC0.61
WACC4.79%
SREA Yearly LT Debt VS Equity VS FCFSREA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B 30B

2.3 Liquidity

SREA has a Current Ratio of 1.59. This is a normal value and indicates that SREA is financially healthy and should not expect problems in meeting its short term obligations.
SREA's Current ratio of 1.59 is amongst the best of the industry. SREA outperforms 100.00% of its industry peers.
SREA has a Quick Ratio of 1.56. This is a normal value and indicates that SREA is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.56, SREA belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.59
Quick Ratio 1.56
SREA Yearly Current Assets VS Current LiabilitesSREA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.24% over the past year.
The Earnings Per Share has been decreasing by -5.31% on average over the past years.
The Revenue has been growing slightly by 6.14% in the past year.
SREA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.04% yearly.
EPS 1Y (TTM)16.24%
EPS 3Y-18.2%
EPS 5Y-5.31%
EPS Q2Q%24.72%
Revenue 1Y (TTM)6.14%
Revenue growth 3Y0.84%
Revenue growth 5Y4.04%
Sales Q2Q%13.51%

3.2 Future

Based on estimates for the next years, SREA will show a small growth in Earnings Per Share. The EPS will grow by 6.96% on average per year.
The Revenue is expected to decrease by -0.54% on average over the next years.
EPS Next Y-0.85%
EPS Next 2Y5.43%
EPS Next 3Y6.4%
EPS Next 5Y6.96%
Revenue Next Year-11.31%
Revenue Next 2Y-3.91%
Revenue Next 3Y-3.57%
Revenue Next 5Y-0.54%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SREA Yearly Revenue VS EstimatesSREA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B
SREA Yearly EPS VS EstimatesSREA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 4.46, the valuation of SREA can be described as very cheap.
SREA's Price/Earnings ratio is rather cheap when compared to the industry. SREA is cheaper than 84.62% of the companies in the same industry.
SREA's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.47.
SREA is valuated cheaply with a Price/Forward Earnings ratio of 4.29.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SREA indicates a rather cheap valuation: SREA is cheaper than 84.62% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of SREA to the average of the S&P500 Index (35.42), we can say SREA is valued rather cheaply.
Industry RankSector Rank
PE 4.46
Fwd PE 4.29
SREA Price Earnings VS Forward Price EarningsSREA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

SREA's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. SREA is cheaper than 84.62% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.98
SREA Per share dataSREA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.43%
EPS Next 3Y6.4%

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.80%, SREA has a reasonable but not impressive dividend return.
With a Dividend Yield of 2.80, SREA pays less dividend than the industry average, which is at 4.19. 84.62% of the companies listed in the same industry pay a better dividend than SREA!
Compared to an average S&P500 Dividend Yield of 2.44, SREA has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.8%

5.2 History

The dividend of SREA decreases each year by -9.71%.
SREA has been paying a dividend for over 5 years, so it has already some track record.
The dividend of SREA decreased recently.
Dividend Growth(5Y)-9.71%
Div Incr Years0
Div Non Decr Years1
SREA Yearly Dividends per shareSREA Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

76.67% of the earnings are spent on dividend by SREA. This is not a sustainable payout ratio.
DP76.67%
EPS Next 2Y5.43%
EPS Next 3Y6.4%
SREA Yearly Income VS Free CF VS DividendSREA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B
SREA Dividend Payout.SREA Dividend Payout, showing the Payout Ratio.SREA Dividend Payout.PayoutRetained Earnings

SEMPRA - SRE 5 3/4 07/01/2079

NYSE:SREA (11/19/2025, 2:37:34 PM)

22.02

-0.06 (-0.27%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)02-23 2026-02-23/amc
Inst Owners91.76%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap14.37B
Revenue(TTM)13.71B
Net Income(TTM)2.11B
Analysts77.14
Price Target23.65 (7.4%)
Short Float %0%
Short Ratio0.4
Dividend
Industry RankSector Rank
Dividend Yield 2.8%
Yearly Dividend2.41
Dividend Growth(5Y)-9.71%
DP76.67%
Div Incr Years0
Div Non Decr Years1
Ex-Date12-15 2025-12-15 (0.3594)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.33%
Min EPS beat(2)4.16%
Max EPS beat(2)20.49%
EPS beat(4)3
Avg EPS beat(4)6.38%
Min EPS beat(4)-7.18%
Max EPS beat(4)20.49%
EPS beat(8)4
Avg EPS beat(8)0.32%
EPS beat(12)8
Avg EPS beat(12)2.78%
EPS beat(16)12
Avg EPS beat(16)4.05%
Revenue beat(2)1
Avg Revenue beat(2)1.51%
Min Revenue beat(2)-4.09%
Max Revenue beat(2)7.1%
Revenue beat(4)1
Avg Revenue beat(4)-3.89%
Min Revenue beat(4)-14.67%
Max Revenue beat(4)7.1%
Revenue beat(8)1
Avg Revenue beat(8)-12.45%
Revenue beat(12)2
Avg Revenue beat(12)-5.38%
Revenue beat(16)6
Avg Revenue beat(16)-1.3%
PT rev (1m)1.9%
PT rev (3m)4.29%
EPS NQ rev (1m)-3.64%
EPS NQ rev (3m)-7.37%
EPS NY rev (1m)0.22%
EPS NY rev (3m)0.38%
Revenue NQ rev (1m)-3.39%
Revenue NQ rev (3m)-3.88%
Revenue NY rev (1m)1.71%
Revenue NY rev (3m)-3.8%
Valuation
Industry RankSector Rank
PE 4.46
Fwd PE 4.29
P/S 1.05
P/FCF N/A
P/OCF 3.03
P/B 0.46
P/tB 0.46
EV/EBITDA 7.98
EPS(TTM)4.94
EY22.43%
EPS(NY)5.14
Fwd EY23.32%
FCF(TTM)-9.02
FCFYN/A
OCF(TTM)7.27
OCFY33%
SpS21.01
BVpS47.78
TBVpS47.78
PEG (NY)N/A
PEG (5Y)N/A
Graham Number72.87
Profitability
Industry RankSector Rank
ROA 1.97%
ROE 6.77%
ROCE 3.55%
ROIC 2.94%
ROICexc 2.94%
ROICexgc 2.94%
OM 22.51%
PM (TTM) 15.38%
GM N/A
FCFM N/A
ROA(3y)3.02%
ROA(5y)3.29%
ROE(3y)9.1%
ROE(5y)9.64%
ROIC(3y)3.3%
ROIC(5y)3.52%
ROICexc(3y)3.32%
ROICexc(5y)3.56%
ROICexgc(3y)3.41%
ROICexgc(5y)3.66%
ROCE(3y)3.99%
ROCE(5y)4.26%
ROICexgc growth 3Y-8.37%
ROICexgc growth 5Y-5.96%
ROICexc growth 3Y-8.1%
ROICexc growth 5Y-5.8%
OM growth 3Y0.45%
OM growth 5Y-2.46%
PM growth 3Y29.87%
PM growth 5Y2.38%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF N/A
Debt/EBITDA 5.6
Cap/Depr 411.78%
Cap/Sales 77.51%
Interest Coverage 2.32
Cash Conversion 83.66%
Profit Quality N/A
Current Ratio 1.59
Quick Ratio 1.56
Altman-Z 0.69
F-Score5
WACC4.79%
ROIC/WACC0.61
Cap/Depr(3y)359.34%
Cap/Depr(5y)353.45%
Cap/Sales(3y)54.96%
Cap/Sales(5y)53.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.24%
EPS 3Y-18.2%
EPS 5Y-5.31%
EPS Q2Q%24.72%
EPS Next Y-0.85%
EPS Next 2Y5.43%
EPS Next 3Y6.4%
EPS Next 5Y6.96%
Revenue 1Y (TTM)6.14%
Revenue growth 3Y0.84%
Revenue growth 5Y4.04%
Sales Q2Q%13.51%
Revenue Next Year-11.31%
Revenue Next 2Y-3.91%
Revenue Next 3Y-3.57%
Revenue Next 5Y-0.54%
EBIT growth 1Y18.88%
EBIT growth 3Y1.29%
EBIT growth 5Y1.48%
EBIT Next Year58.5%
EBIT Next 3Y22.25%
EBIT Next 5Y13.97%
FCF growth 1Y-58.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1.56%
OCF growth 3Y8.5%
OCF growth 5Y9.71%

SEMPRA - SRE 5 3/4 07/01/2079 / SREA FAQ

Can you provide the ChartMill fundamental rating for SEMPRA - SRE 5 3/4 07/01/2079?

ChartMill assigns a fundamental rating of 4 / 10 to SREA.


What is the valuation status for SREA stock?

ChartMill assigns a valuation rating of 6 / 10 to SEMPRA - SRE 5 3/4 07/01/2079 (SREA). This can be considered as Fairly Valued.


How profitable is SEMPRA - SRE 5 3/4 07/01/2079 (SREA) stock?

SEMPRA - SRE 5 3/4 07/01/2079 (SREA) has a profitability rating of 4 / 10.


Can you provide the financial health for SREA stock?

The financial health rating of SEMPRA - SRE 5 3/4 07/01/2079 (SREA) is 3 / 10.


What is the earnings growth outlook for SEMPRA - SRE 5 3/4 07/01/2079?

The Earnings per Share (EPS) of SEMPRA - SRE 5 3/4 07/01/2079 (SREA) is expected to decline by -0.85% in the next year.